If a medication is compounded, it was not made by a pharmaceutical manufacturer. It was prepared by a pharmacy. That is an ordinary and long-established part of medicine, but it works differently from picking up a mass-produced prescription, and the differences are worth understanding before you start.
There are two kinds of compounding operation in the United States, named after the sections of law that govern them. Most people never hear of either until they go looking.
503A: one prescription at a time
A 503A pharmacy compounds for individuals. In the FDA’s own description, the drugs must be compounded “based on the receipt of valid patient-specific prescriptions.” One named patient, one prescription, one preparation.
This is the traditional model, and it is what sits behind most telehealth prescribing. Your clinician writes for you, and the pharmacy prepares that order. A 503A pharmacy is licensed and inspected by its state board of pharmacy rather than registered with the FDA as a compounder.
503B: outsourcing facilities
A 503B outsourcing facility operates at larger scale and under heavier federal oversight. It registers with the FDA. It is, in the agency’s words, “subject to CGMP requirements” — current good manufacturing practice, the same broad framework applied to drug manufacturing — and it is “inspected by FDA according to a risk-based schedule.”
A 503B can also supply a clinic’s general stock rather than filling one named prescription at a time, which is why hospitals and larger practices tend to use them.
The part that applies to both
Whichever prepared your medication, one thing is true of it: compounded medications are not FDA-approved. The FDA states it plainly — “FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.”
This is not a loophole or a scandal. Compounding exists because standardised manufacturing cannot serve every patient: someone needs a different strength, or cannot tolerate a dye or a preservative, or requires a form that is not commercially made. The law permits it deliberately. But the pre-market review that happens for an approved drug has not happened here, and you should know that going in rather than discovering it later.
So which one is better?
That is the question everyone asks, and the honest answer is that it is not a ranking. They do different jobs. A 503B facility carries more federal oversight of its manufacturing processes. A 503A pharmacy is the normal and appropriate route for a medication prescribed specifically for you, which is what individualised telehealth prescribing usually is.
What matters more than the number is whether the basics are in place: a licensed clinician who actually decided this was right for you, a pharmacy licensed to ship to your state, and a provider willing to tell you which pharmacy it is.
How to find out
Ask. It is a reasonable question and any provider worth using will answer it without hesitation:
- Which pharmacy prepares my medication?
- Is it a 503A pharmacy or a 503B outsourcing facility?
- Is it licensed in my state?
- Can I see documentation on the preparation, such as a certificate of analysis?
Vagueness in response to any of those is the finding. A provider who does not know where its own medication comes from, or will not say, has told you what you needed to know.
This article is general information. It is not medical advice, and nothing here is a recommendation to use any particular treatment. Decisions about your health belong between you and a licensed clinician who knows your history.